Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

837 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Relationship between Plasma IP-10/CXCL10 Levels and the Initial Therapeutic Response in Patients Treated with Atezolizumab plus Bevacizumab for Unresectable Hepatocellular Carcinoma.
Takada H, Yamashita K, Osawa L, Komiyama Y, Nakakuki N, Muraoka M, Suzuki Y, Sato M, Kobayashi S, Yoshida T, Takano S, Maekawa S, Enomoto N. Takada H, et al. Among authors: maekawa s. Oncology. 2023;101(10):655-663. doi: 10.1159/000531689. Epub 2023 Jun 28. Oncology. 2023. PMID: 37379802
Interleukin-7 Risk Allele, Lymphocyte Counts, and Autoantibodies for Prediction of Risk of Immune-Related Adverse Events in Patients Receiving Atezolizumab plus Bevacizumab Therapy for Unresectable Hepatocellular Carcinoma.
Takada H, Osawa L, Komiyama Y, Muraoka M, Suzuki Y, Sato M, Kobayashi S, Yoshida T, Takano S, Maekawa S, Enomoto N. Takada H, et al. Among authors: maekawa s. Oncology. 2025;103(1):37-47. doi: 10.1159/000540648. Epub 2024 Jul 30. Oncology. 2025. PMID: 39079513
Impact of Renal Function on the Prognosis of Patients Receiving Atezolizumab/Bevacizumab Combination Therapy and Lenvatinib Monotherapy for Unresectable Hepatocellular Carcinoma.
Takada H, Yamashita K, Osawa L, Komiyama Y, Nakakuki N, Muraoka M, Suzuki Y, Sato M, Takano S, Fukasawa M, Yamaguchi T, Maekawa S, Takahashi K, Uchimura K, Enomoto N. Takada H, et al. Among authors: maekawa s. Oncology. 2023;101(10):609-623. doi: 10.1159/000531111. Epub 2023 Jun 6. Oncology. 2023. PMID: 37279708
Anti-Poiseuille flow by spin Hall effect.
Fujimoto J, Koshibae W, Maekawa S. Fujimoto J, et al. Among authors: maekawa s. PNAS Nexus. 2024 Dec 5;3(12):pgae547. doi: 10.1093/pnasnexus/pgae547. eCollection 2024 Dec. PNAS Nexus. 2024. PMID: 39677370 Free PMC article.
New Surgical Criteria for Intraductal Papillary Mucinous Neoplasm Based on the Age-Adjusted Charlson Comorbidity Index Values and Presence of Solid Component.
Hasegawa H, Fukasawa M, Takano S, Kawakami S, Kuratomi N, Harai S, Yoshimura D, Imagawa N, Okuwaki T, Kuno T, Suzuki Y, Yoshida T, Kobayashi S, Sato M, Maekawa S, Hosomura N, Kawaida H, Ichikawa D, Enomoto N. Hasegawa H, et al. Among authors: maekawa s. Diagnostics (Basel). 2024 Nov 17;14(22):2582. doi: 10.3390/diagnostics14222582. Diagnostics (Basel). 2024. PMID: 39594248 Free PMC article.
837 results